Episode 1: The impact of the Unified Patent Court (UPC) on national patent litigation
20. Januar 2025
Eoin specialises in patents with a particular focus on advising pharmaceutical and biotechnology companies in relation to patent infringement and validity issues.
Eoin has extensive experience in cross-border patent litigation related to blockbuster pharmaceutical drugs representing IP owners, licensees, as well as generic and biosimilar manufacturers. With extensive international experience, Eoin has operated across numerous major jurisdictions.
Eoin is a Authorised Representative before the Unified Patent Court (UPC).
Eoin’s expertise extends to the life cycle management of medicinal products, regulatory advice, and advising on European data and marketing exclusivity.
Eoin has advised a diverse range of clients, especially within the life sciences, technology and telecommunications sectors, on matters concerning the acquisition and licensing of intellectual property rights.
News & Insights: Eoin Martyn
Patents Technology & Life Sciences
Klicken Sie hier für Details
A look at the Unified Patent Court's first year of operation and what lies ahead
25. Juni 2024
.jpg?as=0&dmc=0&iar=0&thn=0&udi=0?as=0&h=206&iar=0&w=366&crop=1&hash=B8184477CB3D9DEA7F82E0F2D360BDB5)
